PDF herunterladen
Am J Perinatol 2015; 32(08): 771-778
DOI: 10.1055/s-0034-1396695
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interaction between Maternal Obesity and 1-Hour Glucose Challenge Test Results on Maternal and Perinatal Outcomes

Akila Subramaniam
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
Victoria C. Jauk
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
Alan Tita
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
Lorie M. Harper
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
› Institutsangaben
Weitere Informationen

Publikationsverlauf

21. Juni 2014

02. Oktober 2014

Publikationsdatum:
29. Dezember 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective The objective of this study was to examine the relationship between positive glucose challenge test (GCT) values and perinatal outcomes stratified by maternal body mass index (BMI).

Study Design Retrospective cohort of singleton gestations with a GCT performed at >20 weeks and documented BMI at entry to care. Subjects were classified by GCT level and BMI. Primary outcomes included large for gestational age (LGA), macrosomia, shoulder dystocia, and pregnancy-induced hypertension. Cochran–Armitage tests for trend and logistic regression were used to compare the GCT categories.

Results A total of 14,525 women met enrollment criteria—8,521 with a GCT < 120 mg/dL and 6,004 with a GCT ≥ 120 mg/dL. When BMI < 25 kg/m2 was considered, the risks were not increased at any level of GCT for any outcome. However, for subjects with BMI ≥ 25 kg/m2, the risk of LGA for a GCT 130 to 134 mg/dL was increased, but not at GCT of 135 to 139 mg/dL (p < 0.001). Similar, but nonsignificant, trends were observed for macrosomia and shoulder dystocia.

Conclusion Increasing GCT is associated with adverse outcomes primarily in women with a BMI ≥ 25 kg/m2. Women with a BMI ≥ 25 kg/m2 and a GCT 135 to 140 mg/dL appear to have less risk of LGA than women with GCT 130 to 134 mg/dL, suggesting a possible effect of diagnosing and treating gestational diabetes mellitus in this group.

Keywords

maternal obesity - gestational diabetes screening - pregnancy outcomes

Note

Poster presentation at the 34th Annual Meeting of the Society for Maternal-Fetal Medicine in New Orleans, LA, February 3–8, 2014.


 

  • References

  • 1 National Institute of Health, US Department of Health and Human Services. Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health; 1995. . NIH publication 95-1468
    Google Scholar
  • 2 Coustan DR. Gestational diabetes. In: National Institutes of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. NIH Publication No. 95–1468. Bethesda, Maryland: NIDDK; 1995: 703-717
    Google Scholar
  • 3 Landon MB, Mele L, Spong CY , et al; Eunice Kennedy Shriver National Institute of Child Health, and Human Development (NICHD) Maternal–Fetal Medicine Units (MFMU) Network. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011; 117 (2, Pt 1): 218-224
    CrossrefPubMedGoogle Scholar
  • 4 Blank A, Grave GD, Metzger BE. Effects of gestational diabetes on perinatal morbidity reassessed. Report of the International Workshop on Adverse Perinatal Outcomes of Gestational Diabetes Mellitus, December 3-4, 1992. Diabetes Care 1995; 18 (1) 127-129
    CrossrefPubMedGoogle Scholar
  • 5 Stamilio DM, Olsen T, Ratcliffe S, Sehdev HM, Macones GA. False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol 2004; 103 (1) 148-156
    CrossrefPubMedGoogle Scholar
  • 6 Dornhorst A, Rossi M. Risk and prevention of type 2 diabetes in women with gestational diabetes. Diabetes Care 1998; 21 (Suppl. 02) B43-B49
    PubMedGoogle Scholar
  • 7 Metzger BE, Lowe LP, Dyer AR , et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
    CrossrefPubMedGoogle Scholar
  • 8 Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003; 101 (2) 380-392
    CrossrefPubMedGoogle Scholar
  • 9 Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev 2009; (3) CD003395
    PubMedGoogle Scholar
  • 10 Metzger BE, Coustan DR ; The Organizing Committee. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998; 21 (2) (Suppl. 02) B161-B167
    PubMedGoogle Scholar
  • 11 Leikin EL, Jenkins JH, Pomerantz GA, Klein L. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol 1987; 69 (4) 570-573
    PubMedGoogle Scholar
  • 12 Figueroa D, Landon MB, Mele L , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol 2013; 121 (6) 1241-1247
    CrossrefPubMedGoogle Scholar
  • 13 Wolfe KB, Rossi RA, Warshak CR. The effect of maternal obesity on the rate of failed induction of labor. Am J Obstet Gynecol 2011; 205 (2) e1-e7
    CrossrefPubMedGoogle Scholar
  • 14 Owens LA, O'Sullivan EP, Kirwan B, Avalos G, Gaffney G, Dunne F ; ATLANTIC DIP Collaborators. ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose-tolerant women. Diabetes Care 2010; 33 (3) 577-579
    CrossrefPubMedGoogle Scholar
  • 15 Catalano PM, McIntyre HD, Cruickshank JK , et al; HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012; 35 (4) 780-786
    CrossrefPubMedGoogle Scholar
  • 16 Marshall NE, Guild C, Cheng YW, Caughey AB, Halloran DR. The effect of maternal body mass index on perinatal outcomes in women with diabetes. Am J Perinatol 2014; 31 (3) 249-256
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 17 Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126 (5) 555-564
    CrossrefPubMedGoogle Scholar
  • 18 HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 2010; 117 (5) 575-584
    CrossrefPubMedGoogle Scholar
  • 19 Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med 2005; 17 (1) 29-34
    CrossrefPubMedGoogle Scholar
  • 20 Stuebe AM, Landon MB, Lai Y , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD. Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol 2012; 207 (1) e1-e7
    PubMedGoogle Scholar
  • 21 Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191 (3) 964-968
    CrossrefPubMedGoogle Scholar
  • 22 Jensen DM, Damm P, Sørensen B , et al. Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol 2003; 189 (1) 239-244
    CrossrefPubMedGoogle Scholar
  • 23 Wetta LA, Biggio JR, Cliver S, Abramovici A, Barnes S, Tita AT. Is midtrimester vitamin D status associated with spontaneous preterm birth and preeclampsia?. Am J Perinatol 2014; 31 (6) 541-546
    Artikel in Thieme ConnectPubMedGoogle Scholar